Subscribe to Print Edition | Fri., May 02, 2008 Nisan 27, 5768 | | Israel Time: 02:39 (EST+7) web haaretz.com   Back to Homepage Rosner's Domain Diplomacy Defense Jewish World Opinion National Print Edition Advertising Books Arts & Leisure Business Real Estate Easy Start Travel Week's End Anglo File

Israeli companies manage to sell ARS portfolios without losses By Yoram Gabison Tags: Teva pharmaceutical  The sinking structured bond market dragged down the portfolio values of many Israeli companies traded in the United States. The companies had sought surplus yields from highly rated, liquid instruments such as auction rate securities (ARS) as part of their cash-flow management. When the credit crisis erupted in July, the companies suddenly found themselves with a bag full of non-negotiable paper. Lately, however, the ARS market appears to have stabilized and companies that held onto these securities could soon report the sale of their ARS holdings without suffering any losses. Hedge funds and investment companies may even be rekindling an interest in ARS. These securities are 10- to 40-year negotiable bonds issued by companies, local authorities, institutions and credit card companies, with interest that changes after one, two, four or five weeks. The liquidity of the ARS is based on the issuing companies' cash flow, from credit card transactions, for example, or from housing loans payments, which earn the bonds a high AAA rating. Advertisement ARS are ostensibly long-term financial instruments, but their redemption period is actually the frequency with which auctions are held to set the interest rates. Last summer, the auctions were canceled due to a lack of interested buyers. Teva Pharmaceutical is the most prominent Israeli company with an ARS portfolio. As of December 31, 2007, Teva had $651 million in ARS. Following a failed auction on $387 million in ARS, Teva reclassified them as a long-term investment, but their lack of tradability made it difficult to assess their actual value. Based on a model developed by Teva, the company provisioned for a temporary decline in the portfolio's worth, recording it at $444 million in Teva's annual financial reports (F-20) for 2007. Capital market sources estimate that Teva has been gradually downsizing its ARS holding, to a current value of $300 million, selling the securities each time without losses. Ormat Industries was stuck with $43.7 million in ARS at the end of 2007, and like Teva, reclassified them as a long-term investment. Unlike Teva, however, Ormat's ARS portfolio was assessed by an external appraiser, resulting in a permanent write-off of $8.9 million, as a securities loss, as of March 31, 2008. Still, in the past few months Ormat has likely been reducing its ARS holdings without further losses. Bookmark to del.icio.us   Hamas on the Holocaust Al-Aqsa TV claims Jews concocted the Holocaust. Grasping genocide How a non-Jew in Israel came to understand the Holocaust.

Read & React IDF chief: We take calls for Israel's destruction seriously Responses: 152 Israel Harel: Jewish guilt over Gaza deaths weakens us in fight for Israel's existence Responses: 161 Hamas TV: 'Satanic Jews' planned, perpetrated Holocaust Responses: 151 Palestinians: IDF kills 62-year-old Gazan; 9 Qassams hit Negev Responses: 69 Mofaz, at Yale: Iran could have nuke bomb technology this year Responses: 34 More Headlines 22:21 Police summon PM for urgent questioning under caution 20:24 IDF chief at Auschwitz: We take calls for Israel's destruction seriously 17:34 Hamas TV claims 'Satanic Jews' planned, perpetrated Holocaust 02:20 Rice: Israelis and Palestinians must agree on final borders 22:56 Yellow patch, Blue victory: U.K. media praise Grant after Chelsea win 21:12 Ma'aleh Adumim mayor: I got impression that gov't plans to divide J'lem 12:03 Son gets Dad's Auschwitz tattoo on own arm 23:33 Leftist group: Police barring us from monitoring Hebron settlers 01:02 Eitan's wheeling and dealing keeps Pensioners Party intact 20:07 Top U.S. official: America would look favorably on PA request for additional funding 16:36 South Africa withdraws request to host 'Durban 2' conference Previous Editions Select Day 01 may 30 apr 29 apr 28 apr 27 apr 25 apr 24 apr 23 apr 22 apr 21 apr 20 apr 18 apr

Special Offers Advertisement Pardes Institute Summer Sessions http://www.pardes.org.il/ FAREWELL ISRAEL New Film The Coming War for Islamic Revival - View Movie Trailer The interest rates haven't changed But your profits will! Learn Hebrew online with Israel's best teachers Sign up for a trial lesson today Free the Palestinians from: Corrupt Kleptocracy, Tyrannical Theocracy, Abysmal Anarchy Fattal Hotel Chain Perfectly located hotels on best resorts of Israel. ISRAEL BONDS Build Israel Israel bonds - a multi-purpose way to celebrate Israel's 60th Eldan Rent a Car Israel's leading car rental company offers you a 20% discount on all online reservations Junkyard Junk a car - get free towing nationwide and a tax-deductible receipt

Home | TV | Print Edition | Diplomacy | Opinion | Arts & Leisure | Sports | Jewish World | Underground | Site rules |

Real Estate in Israel

Haaretz.com, the online edition of Haaretz Newspaper in Israel, offers real-time breaking news, opinions and analysis from Israel and the Middle East. Haaretz.com provides extensive and in-depth coverage of Israel, the Jewish World and the Middle East, including defense, diplomacy, the Arab-Israeli conflict, the peace process, Israeli politics, Jerusalem affairs, international relations, Iran, Iraq, Syria, Lebanon, the Palestinian Authority, the West Bank and the Gaza Strip, the Israeli business world and Jewish life in Israel and the Diaspora.

© Copyright  Haaretz. All rights reserved